Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg‐positive chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|2|473-481

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.2, 2015-02, pp. : 473-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On‐treatment prediction of sustained response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1540-1548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 341-349

Karger

Access to resources Recommend Favorite

HLA‐DP, IL28B gene polymorphisms and IFN

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1000-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Follow-Up of HBeAg-Positive Young Adult Japanese Patients Treated with Corticosteroid Withdrawal Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 339-345

Karger

Access to resources Recommend Favorite

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG‐interferon

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 318-327

John Wiley & Sons Inc

Access to resources Recommend Favorite